image
Phathom Pharmaceuticals, Inc. PHAT
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 8.78
-3.41 %
$ 600 M
Market Cap
-1.53
P/E
FINANCIAL REPORTS

Reports

Report Date Revenue YoY Net Income YoY Operating Income YoY View
Annual Report FY 10-K 2023-12-31 0.00% 9.60% 2.97%
Annual Report FY 10-K 2022-12-31 0.00% -50.58% -27.66%
Annual Report FY 10-K 2021-12-31 0.00% -11.08% -7.49%
Annual Report FY 10-K 2020-12-31 0.00% 36.44% -18.31%
Annual Report FY 10-K 2019-12-31 0.00% -16184.47% -8570.61%
Annual Report FY 10-K 2018-12-31 0.00% 0.00% 0.00%
Quarterly Report Q3 8-K 2024-09-30 0.00% -97.90% -98.54%
Quarterly Report Q2 8-K 2024-06-30 0.00% -123.23% -143.84%
Quarterly Report Q1 8-K 2024-03-31 0.00% -119.95% -132.58%
Quarterly Report Q4 8-K 2023-12-31 0.00% -25.40% -49.81%
Quarterly Report Q3 8-K 2023-09-30 0.00% 27.51% 16.15%
Quarterly Report Q2 8-K 2023-06-30 0.00% 19.55% 30.12%
Quarterly Report Q1 8-K 2023-03-31 0.00% 13.26% 20.65%
Quarterly Report Q4 8-K 2022-12-31 0.00% -77.11% -41.17%
Quarterly Report Q3 8-K 2022-09-30 0.00% -62.71% -28.34%
Quarterly Report Q2 8-K 2022-06-30 0.00% -39.31% -28.44%
Quarterly Report Q1 8-K 2022-03-31 0.00% -24.63% -12.87%
Quarterly Report Q4 8-K 2021-12-31 0.00% 33.31% 36.99%
Quarterly Report Q3 8-K 2021-09-30 0.00% -7.50% -0.94%
Quarterly Report Q2 8-K 2021-06-30 0.00% -73.22% -76.41%
Quarterly Report Q1 8-K 2021-03-31 0.00% -73.00% -64.83%
Quarterly Report Q4 8-K 2020-12-31 0.00% 45.19% -234.16%
Quarterly Report Q3 8-K 2020-09-30 0.00% 49.93% -422.60%
Quarterly Report Q2 8-K 2020-06-30 0.00% 75.96% 75.88%
Quarterly Report Q1 8-K 2020-03-31 0.00% -1509.99% -1561.91%
Quarterly Report Q4 8-K 2019-12-31 0.00% -20149.17% -3379.60%
Quarterly Report Q3 8-K 2019-09-30 0.00% -23386.90% -2244.03%
Quarterly Report Q2 8-K 2019-06-30 0.00% -34048.64% -32711.86%
Quarterly Report Q1 8-K 2019-03-31 0.00% -386.77% -384.58%
Quarterly Report Q4 8-K 2018-12-31 0.00% 0.00% 0.00%
Quarterly Report Q3 8-K 2018-09-30 0.00% 0.00% 0.00%
Quarterly Report Q2 8-K 2018-06-30 0.00% 0.00% 0.00%
Quarterly Report Q1 8-K 2018-03-31 0.00% 0.00% 0.00%